To study the effect of Jalaukavcharan and Amoxicillin 500mg and Clavulanic acid 125mg in Nasur with special referance to Acute Dacryocystitis

A Randomized Controlled Clinical Trial Of Jalaukavacharan and Amoxicillin 500mg and Clavulanic acid 125mg In Puyalas With Special Reference to Acute Dacryocystitis

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046469

Enrollment

Registered

2022-10-13

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H049- Disorder of lacrimal system, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients having classical sign and symptoms of Puyalasa 2 patient will be selected irrespective of sex religion occupation

Exclusion criteria

Exclusion criteria: 1 Patient with congenital Dacryocystitis 2 Patient with other occular disease 3 Recently operated patients 4 Patients with other systemic disorder like DM HTN

Design outcomes

Primary

Measure	Time frame
Uttamupashaya- 75-100% Madhyanupashaya- 50-74% Alpaupashaya- 25-49% Anupashaya- less than 25%Timepoint: 0th day 3rd day 5th day 15th day 30th day 60th day 90th day	—

Secondary

Measure	Time frame
Remission in symptoms of Epiphora Remission in redness at medial canthus Remission in Acute DacryocystitisTimepoint: 7th day 14th day 30th day 75th day	—

Countries

India

Contacts

Public ContactDevendra R Chaudhari

Vidarbha Ayurved Mahavidyalaya Amravati

Chaudharidevendra5@gmail.com8208501419

Outcome results